Biological impact of xeno-free chemically defined cryopreservation medium on amniotic epithelial cells

Stem Cell Research & Therapy

Brendan H. Grubbs¹  Irving Garcia²  Anthony Gonzalez²  Elton Zhou²  Wisia Wong²  Toshio Miki² 

[1] Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA;Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

关键词: Chemically defined media;    Xeno-free;    Serum-free;    Cryopreservation;    Placenta-derived stem cells;    Amniotic epithelial cells;    Placenta;   

Others  :  1235631
DOI  :  10.1186/s13287-015-0258-z

 received in 2015-03-12, accepted in 2015-12-04,  发布年份 2016

【 摘 要 】

Background

Amnion-derived stem cells have been proposed for cell replacement therapy and tissue regeneration. An easily accessible cell source, the placenta, allows us to potentially establish a bio-bank of cells for immunotype matched clinical applications. Several xeno-free (XF) cryopreservation media are currently available for pluripotent stem cells, however, these media have not yet been evaluated for the cryopreservation of amnion-derived stem cells.

Methods

Human amniotic epithelial cells were collected using standard protocols, and stored at −160 °C in one of five commercially available media. Cells frozen in standard media containing fetal bovine serum served as controls. Cells were then thawed, and evaluated for viability, mitochondrial membrane stability, and senescence status. Quantitative real time PCR was utilized to assess for expression of stem cell genes, and flow cytometry was used to identify the stem cell surface markers.

Results

Cell recovery and repopulation assays indicated no significant difference between XF media versus standard cryopreservation medium. In addition, no impact was observed on the senescence status, the cytostructural or mitochondrial morphology between the tested cryopreservation media. Differences were observed on the expression of stem cell marker genes (OCT4, SOX2, and NANOG) and a cell surface marker (TRA1-60) following cryopreservation in different chemically defined XF media, however, these were not statistically significant.

Conclusions

Xeno-free cryopreservation of human amnion-derived stem cells is feasible and can be standardized to establish a bio-bank with human amnion-derived stem cells for future clinical application. Optimization of this media may allow for improved preservation of stem cell-like characteristics.

【 授权许可】

   
2016 Miki et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

【 参考文献 】

• [1]Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring H-J, Evangelista M, et al.: Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008, 26:300-11.
• [2]Ilancheran S, Moodley Y, Manuelpillai U: Human Fetal Membranes: A Source of Stem Cells for Tissue Regeneration and Repair? Placenta 2009, 30:2-10.
• [3]Miki T: Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther 2011, 2:25. BioMed Central Full Text
• [4]Miki T, Grubbs B: Therapeutic potential of placenta-derived stem cells for liver diseases: Current status and perspectives. J Obstet Gynaecol Res 2014, 40:360-8.
• [5]Miki T, Lehmann T, Cai H, Stolz DB, Strom SC: Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23:1549-59.
• [6]Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U: Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 2007, 77:577-88.
• [7]Manuelpillai U, Lourensz D, Vaghjiani V, Tchongue J, Lacey D, Tee J-Y, et al.: Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis. PLoS One 2012., 7Article ID e38631
• [8]Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, et al.: Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology 2013, 57:1017-23.
• [9]Liu YH, Vaghjiani V, Tee JY, To K, Cui P, Oh DY, et al.: Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One 2012., 7Article ID e35758
• [10]Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, et al.: Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS One 2013., 8Article ID e69299
• [11]Toda A, Okabe M, Yoshida T, Nikaido T: The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 2007, 105:215-28.
• [12]Parolini O, Alviano F, Bergwerf I, Boraschi D, De Bari C, De Waele P, et al.: Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev 2010, 19:143-54.
• [13]Strom SC, Skvorak K, Gramignoli R, Marongiu F, Miki T: Translation of amnion stem cells to the clinic. Stem Cells Dev 2013, 22(Suppl 1):96-102.
• [14]Nakatsuji N, Nakajima F, Tokunaga K: HLA-haplotype banking and iPS cells. Nat Biotechnol 2008, 26:739-40.
• [15]Massie I, Selden C, Hodgson H, Fuller B, Gibbons S, Morris GJ: GMP Cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process. Tissue Eng Part C Methods 2014, 20:1-46.
• [16]Roy S, Arora S, Kumari P, Ta M: A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton’s jelly mesenchymal stem cells. Cryobiology 2014, 68:467-72.
• [17]Miyamoto Y, Noguchi H, Yukawa H, Oishi K, Matsushita K, Iwata H, et al.: Cryopreservation of induced pluripotent stem cells. Cell Med 2012, 3:89-95.
• [18]Cohen RI, Thompson ML, Schryver B, Ehrhardt RO: Standardized cryopreservation of pluripotent stem cells. Curr Protoc Stem Cell Biol 2014, 28:Unit 1C.14.
• [19]Jorns C, Ellis EC, Nowak G, Fischler B, Nemeth A, Strom SC, Ericzon BG: Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med 2012, 272:201-23.
• [20]Gook DA, Edgar DH: Human oocyte cryopreservation. Hum Reprod Update 2007, 13:591-605.
• [21]Li Y, Tan J-C, Li L-S: Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil Steril 2010, 93:999-1005.
• [22]Karlsson JOM, Toner M: Long-term storage of tissues by cryopreservation: Critical issues. Biomaterials 1996, 17:243-56.
• [23]Mitry RR, Lehec SC, Hughes RD: Cryopreservation of human hepatocytes for clinical use. Methods Mol Biol 2010, 640:107-13.
• [24]Polchow B, Kebbel K, Schmiedeknecht G, Reichardt A, Henrich W, Hetzer R, et al.: Cryopreservation of human vascular umbilical cord cells under good manufacturing practice conditions for future cell banks. J Transl Med 2012, 10:98. BioMed Central Full Text
• [25]Stacy GN, Masters JR: Cryopreservation and banking of mammalian cell lines. Nat Protoc 2008, 3:1981-89.
• [26]Miki T, Marongiu F, Dorko K, Ellis ECS, Strom SC: Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol 2010, Chapter 1:Unit 1E.3.
• [27]Hall SM, Evans J, Haworth SG: Influence of cold preservation on the cytoskeleton of cultured pulmonary arterial endothelial cells. Am J Respir Cell Mol Biol 1993, 9:106-14.
• [28]Ahn HJ, Sohn IP, Kwon HC, Jo DH, Park YD, Min CK: Characteristics of the cell membrane fluidity, actin fibers, and mitochondrial dysfunctions of frozen-thawed two-cell mouse embryos. Mol Reprod Dev 2002, 61:466-76.
• [29]Wilson JM, Caceci T, Potter GD, Kraemer DC: Ultrastructure of cryopreserved horse embryos. J Reprod Fertil Suppl 1987, 35:405-17.
• [30]Sammut IA, Thorniley MS, Simpkin S, Fuller BJ, Bates TE, Green CJ: Impairment of hepatic mitochondrial respiratory function following storage and orthotopic transplantation of rat livers. Cryobiology 1998, 36:49-60.
• [31]Ogier de Baulny B, Labbé C, Maisse G: Membrane integrity, mitochondrial activity, ATP content, and motility of the European catfish (Silurus glanis) testicular spermatozoa after freezing with different cryoprotectants. Cryobiology 1999, 39:177-84.
• [32]Stéphenne X, Najimi M, Ngoc DK, Smets F, Hue L, Guigas B, et al.: Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transplant 2007, 16:409-19.
• [33]Eroglu A, Russo MJ, Bieganski R, Fowler A, Cheley S, Bayley H, et al.: Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nat Biotechnol 2000, 18:163-7.
• [34]Miyamoto Y, Suzuki S, Nomura K, Enosawa S: Improvement of hepatocyte viability after cryopreservation by supplementation of long-chain oligosaccharide in the freezing medium in rats and humans. Cell Transplant 2006, 15:911-9.
• [35]Miyamoto Y, Teramoto N, Hayashi S, Enosawa S: An improvement in the attaching capability of cryopreserved human hepatocytes by a proteinaceous high molecule, sericin, in the serum-free solution. Cell Transplant 2010, 19:701-6.
• [36]Unger C, Skottman H, Blomberg P, Sirac dilber M, Hovatta O: Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 2008, 17:R48-53.
• [37]Holm F, Ström S, Inzunza J, Baker D, Strömberg A-M, Rozell B, et al.: An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells. Hum Reprod 2010, 25:1271-9.
• [38]Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, et al.: A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 2014, 4:3594.
• [39]Yoshitaka M, Koichi O, Hiroshi Y, Hirofumi N, Masahiro S, Hisashi I, et al.: Cryopreservation of Human Adipose Tissue-Derived Stem/Progenitor Cells. Cryobiol Cryotechnol 2010, 56:55-8.
• [40]Saliem M, Holm F, Tengzelius RB, Jorns C, Nilsson LM, Ericzon BG, et al.: Improved cryopreservation of human hepatocytes using a new xeno free cryoprotectant solution. World J Hepatol 2012, 4:176-83.